Company: IPHYF
Filing Date: 2025-04-30
Form Type: 20-F
Source: 0001598599-25-000042
Chunk: 288

Company: Innate Pharma SA
Filing Date: 2025-04-30
Form: 20-F
Item: Item 12
Chunk 288
---
s pursuant to (i) stock dividends or other free stock distributions, or (ii) exercise of rights to purchase additional ADSs                                                            Up to U. S. 5¢ per ADS held                                                                      
  Distribution of securities other than ADSs or rights to purchase additional ADSs (e.g., upon a spin-off)                                                                                                  Up to U. S. 5¢ per ADS held                                                                      
  ADS Services                                                                                                                                                                                              Up to U. S. 5¢ per ADS held on the applicable record date(s) established by the depositary bank  
  Registration of ADS transfers (e.g., upon a registration of the transfer of registered ownership of ADSs, upon a transfer of ADSs into DTC and vice versa, or for any other reason)                       Up to U. S. 5¢ per ADS (or fraction thereof) transferred                                         
  Conversion of ADSs of one series for ADSs of another series (e.g., upon conversion of Partial Entitlement ADSs for Full Entitlement ADSs, or upon conversion of Restricted ADSs (each as defined ...      Up to U. S. 5¢ per ADS (or fraction thereof) converted                                           

ADS holders are responsible to pay certain charges such as:

• taxes (including applicable interest and penalties) and other governmental charges;

• the registration fees as may from time to time be in effect for the registration of ordinary shares on the share register and applicable to transfers of ordinary shares to or from the name of the

custodian, the depositary bank or any nominees upon the making of deposits and withdrawals, respectively;

• certain cable, telex and facsimile transmission and delivery expenses;

• the fees, expenses, spreads, taxes and other charges of the depositary bank and/or service providers (which may be a division, branch or affiliate of the depositary bank) in the conversion of foreign currency;

• the reasonable and customary out-of-pocket expenses incurred by the depositary bank in connection with compliance with exchange control regulations and other regulatory requirements applicable to ordinary shares, ADSs and ADRs; and

• the fees, charges, costs and expenses incurred by the depositary bank, the custodian, or any nominee in connection with the ADR program.

ADS fees and charges for (i) the issuance of ADSs, and (ii) the cancellation of ADSs are charged to the person for whom the ADSs are issued (in the case of ADS issuances) and to the person for whom ADSs are cancelled (in the case of ADS